CAS 681492-22-8|Delamanid

Introduction:Basic information about CAS 681492-22-8|Delamanid, including its chemical name, molecular formula, synonyms, physicochemical properties, and safety information, etc.
Common NameDelamanid
CAS Number681492-22-8Molecular Weight534.484
Density1.5±0.1 g/cm3Boiling Point653.7±65.0 °C at 760 mmHg
Molecular FormulaC25H25F3N4O6Melting Point/
MSDS/Flash Point349.1±34.3 °C

Names

Name(2R)-2-methyl-6-nitro-2-[[4-[4-[4-(trifluoromethoxy)phenoxy]piperidin-1-yl]phenoxy]methyl]-3H-imidazo[2,1-b][1,3]oxazole
SynonymMore Synonyms

Delamanid BiologicalActivity

DescriptionDelamanid, a newer mycobacterial cell wall synthesis inhibitor, inhibits the synthesisi of mucolic acids, cruciala component of the cell wall of the Mycobacterium tuberculosis complex.In vitro: inhibits the synthesisi of mucolic acids, cruciala component of the cell wall of the Mycobacterium tuberculosis complex.[1]In in-vitro studies, delamanid shows more potent antibacterial activity against drug-susceptible and drug-resistant strains of M. tuberculosis.[2] Delamanid do not affect rifampin, pyrazinamide, and isoniazid exposure; the ethambutol AUCτ and Cmax values are about 25% higher with delamanid coadministration. [3] In vivo: Twice-daily oral dosing of delamanid at 30 mg kg-1 for 5 days resulted in sterile cures in a mouse model of VL. [4]
Related CatalogSignaling Pathways >>Anti-infection >>BacterialResearch Areas >>Cancer
References

[1]. Sotgiu G et al. Delamanid (OPC-67683) for treatment of multi-drug-resistant tuberculosis. Expert Rev Anti Infect Ther. 2015 Mar;13(3):305-15.

[2]. Xavier AS et al. Delamanid: A new armor in combating drug-resistant tuberculosis. J Pharmacol Pharmacother. 2014 Jul;5(3):222-4

[3]. Mallikaarjun S et al. Delamanid Coadministered with Antiretroviral Drugs or Antituberculosis Drugs Shows No Clinically Relevant Drug-Drug Interactions in Healthy Subjects. Antimicrob Agents Chemother. 2016 Sep 23;60(10):5976-85.

[4]. Patterson S et al.The anti-tubercular drug delamanid as a potential oral treatment for visceral leishmaniasis. Elife. 2016 May 24;5.

Chemical & Physical Properties

Density1.5±0.1 g/cm3
Boiling Point653.7±65.0 °C at 760 mmHg
Molecular FormulaC25H25F3N4O6
Molecular Weight534.484
Flash Point349.1±34.3 °C
Exact Mass534.172607
PSA103.80000
LogP4.75
Vapour Pressure0.0±2.0 mmHg at 25°C
Index of Refraction1.611
InChIKeyXDAOLTSRNUSPPH-XMMPIXPASA-N
SMILESCC1(COc2ccc(N3CCC(Oc4ccc(OC(F)(F)F)cc4)CC3)cc2)Cn2cc([N+](=O)[O-])nc2O1
Storage condition-20℃

Synonyms

Delamanid
Imidazo[2,1-b]oxazole, 2,3-dihydro-2-methyl-6-nitro-2-[[4-[4-[4-(trifluoromethoxy)phenoxy]-1-piperidinyl]phenoxy]methyl]-, (2R)-
(2R)-2-methyl-6-nitro-2-[(4-{4-[4-(trifluoromethoxy)phenoxy]piperidin-1-yl}phenoxy)methyl]-2,3-dihydroimidazo[2,1-b][1,3]oxazole
(2R)-2-Methyl-6-nitro-2-[(4-{4-[4-(trifluoromethoxy)phenoxy]-1-piperidinyl}phenoxy)methyl]-2,3-dihydroimidazo[2,1-b][1,3]oxazole
UNII-8OOT6M1PC7
OPC-67683
CAS 442908-10-3|Vipadenant
CAS 839713-36-9|Nelotanserin
Recommended......
TOP